Congratulations to UW Ob-Gyn resident Connor Wang, MD, PGY-3, who is lead author on a new publication in Gynecologic Oncology Reports!
In the article “When we open and close: postoperative outcomes after aborted primary cytoreduction for ovarian cancer”, Wang and co-authors Matt Wagar, MD, PGY-4, Amy Godecker, PhD, Ahmed Al-Niaimi, MD, and David Kushner, MD aimed to expand available data to help counsel patients about outcomes after aborted primary debulking surgery.
This retrospective study looked at postsurgical morbidity for 43 patients who underwent aborted primary debulking surgery for advanced ovarian cancer:
“All patients subsequently underwent ICS, [interval cytoreductive surgery] with 21 (48.8%) achieving no residual macroscopic disease and 21 (48.8%) to ≤1cm of macroscopic disease. After AD [aborted primary debulking], 16 (37.2%) experienced at least one G≥3 event within the first 30 days. The most common complication was gastrointestinal complications. Preoperative albumin was the only significant predictor for G≥3 complication after AD.”
Read the whole study here!